Informa Life Sciences is part of the Knowledge and Networking Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.
Examine the current obstacles in pricing, reimbursement, access and the healthcare & life sciences infrastructure. What is the current “state of play”? And perhaps most importantly, understand the changes in outcome for patients and the patient perspective.
Examine & Understand the impact of the growing industry pipeline, the evolution of clinical trial landscape and access to available real-world data on Oncology & therapeutic development
Gain insight into evolving market access and commercialization models that optimize strategy and ensure patient access to new therapies. How do you differentiate your therapeutic in a crowded space? Explore the need for more therapeutics for current unmet needs.
A look at a creative global collaboration to develop & commercialize Immuno-Oncology treatments.
Understand how diagnostics are enabling a more targeted approach to treat an increasing number of cancers.
How do you separate the hype from reality in today Drug Discovery? Cloud Pharmaceuticals is the leader of AI-based (augmented by data mining and computational chemistry) drug design and development. We will showcase here AI deployment and automation while maintaining chemical information that is crucial for drug discovery.
How will customizing treatments to individual needs impact the patient journey and treatment?
Explore how Oncolytic Viruses will increase the chances that patients will respond to Immunotherapies.